Thalidomide (K17)

Cat. No.: OB0225WX-2399

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Thalidomide (K17) is an immunomodulatory molecule that binds to and inhibits cereblon (CRBN), a substrate receptor of the cullin-4 E3 ubiquitin ligase complex.

Synonym: K17; 50-35-1; Thalidomide; Thalomid; 2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione; Contergan; Distaval; Pantosediv; Softenon; Kevadon; Theophilcholine; Algosediv; Corronarobetin; Ectiluran; Enterosediv; Gastrinide; Nerosedyn; Neurosedin; Neurosedym; Noctosediv; Profarmil; Psycholiquid; Psychotablets; Quietoplex; Sandormin; Sedisperil; Shinnibrol; Telargean; Thalinette; Valgraine; Asmadion; Asmaval; Bonbrain; Calmore; Calmorex; Glutanon; Grippex; Hippuzon; Imidene; Neosedyn; Neosydyn; Neufatin; Neurodyn; Nevrodyn; Noxodyn; Quetimid; Sedimide; Sedoval; Sleepan; Softenil; Talargan; Talimol; Talismol; Telagan; Tensival; Yodomin; Glupan; Isomin; Nibrol; Pangul; Sedin; Slipro; Thalin; Valgis; N-Phthaloylglutamimide; Predni-Sediv; Imida-lab; Sedalis sedi-lab; N-Phthalylglutamic acid imide; Neaufatin; Asidon 3; Pro-ban M; 3-Phthalimidoglutarimide; Shin-naito S; Imidan (peyta); Neurosedyn; Ulcerfen; Talidomida; alpha-Phthalimidoglutarimide; Distaxal; Distoval; Kedavon; Thalomide; Thaled; (+-)-Thalidomide; K-17; 2,6-Dioxo-3-phthalimidopiperidine; Thalidomide Celgene; Thalidomidum; Bonbrrin; Pharmion; Talidomide; Telargan; Celgene; Pro-Bam M; Sedalis; N-(2,6-Dioxo-3-piperidyl)phthalimide; alpha-N-Phthalylglutaramide; Glutarimide, 2-phthalimido-; N-Phthalyl-glutaminsaeure-imid; alpha-(N-Phthalimido)glutarimide; Synovir; Myrin; K 17; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline; HSDB 3586; 2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione; 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-; 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)-; 1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)-; 2-((3RS)-2,6-Dioxopiperidin-3-yl)isoindoline-1,3-dione

CAS No.: 50-35-1

Compound CID: 5426

Formula: C₁₃H₁₀N₂O₄

Formula Weight: 258.23

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Thalidomide (K17) is employed in pharmacological and immunological research to investigate its anti-inflammatory and anti-angiogenic effects through the modulation of TNF-alpha production and cereblon signaling.